The IMAGINE trial has commenced with first vaccinations of MTBVAC, a novel tuberculosis vaccine candidate, administered in South Africa on February 19, 2025, marking a significant step in combating the world's deadliest infectious disease.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.